Julie Cherrington

Julie Cherrington

Director/Board Member bij SYNCONA LIMITED

Vermogen: 7 336 $ op 31-01-2024

66 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Julie Michele Cherrington is a businessperson who has been at the helm of 10 different companies.
Presently, she holds the position of Chairman at Actym Therapeutics, Inc., Chief Executive Officer & Director at QUE Oncology, Inc. and Venture Partner at Brandon Capital Partners Pty Ltd.
Dr. Cherrington is also on the board of Syncona Ltd., Kisoji Biotechnology, Inc. and Sardona Therapeutics, Inc. and Member of American Society of Clinical Oncology, Inc. and Member of American Society of Hematology.
Julie Michele Cherrington previously occupied the position of Chairman at Xenome Ltd., President, Chief Executive Officer & Director at Pathway Therapeutics, Inc. and President, Chief Executive Officer & Director at Pathway Therapeutics Ltd.
(a subsidiary of Pathway Therapeutics, Inc.), President & Chief Executive Officer for Zenith Capital Corp.
(Alberta), President, Chief Executive Officer & Director at Arch Oncology, Inc., President & Chief Executive Officer at Revitope Oncology, Inc., President at Phenomix Corp.
and President for Phenomix Australia Pty Ltd.
(a subsidiary of Phenomix Corp.), Virology Director at Gilead Sciences, Inc., Member of American Association for Cancer Research, VP-Preclinical Research & Exploratory Development at Sugen, Inc. and Member of American Diabetes Association.
She received a doctorate from the University of Minnesota, a graduate degree and an undergraduate degree from the University of California, Davis and a doctorate from Stanford University.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
04-08-2022 6 217 ( 0.00% ) 7 336 $ 31-01-2024
23-01-2024 0 ( -.--% ) - $ 31-12-2023

Actieve functies van Julie Cherrington

BedrijvenFunctieBegin
SYNCONA LIMITED Director/Board Member 01-02-2022
Private Equity Investor -
Sardona Therapeutics, Inc. Director/Board Member 01-02-2021
Director/Board Member 01-08-2021
Chief Executive Officer 01-09-2020
Corporate Officer/Principal 07-04-2011
Corporate Officer/Principal 07-04-2011
Chairman 12-05-2022
Alle actieve functies van Julie Cherrington

Eerdere bekende functies van Julie Cherrington

BedrijvenFunctieEinde
MIRATI THERAPEUTICS Director/Board Member 23-01-2024
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░ ░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Ervaring van Julie Cherrington in detail bekijken

Opleiding van Julie Cherrington

Stanford University Doctorate Degree
University of California, Davis Graduate Degree
University of Minnesota Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Julie Cherrington in detail bekijken

Connecties

100 +

Eerstegraads connecties

30

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven5
GILEAD SCIENCES, INC.

Health Technology

ZENITH CAPITAL CORP.

Health Technology

MIRATI THERAPEUTICS

Health Technology

VAXART, INC.

Health Technology

RAKOVINA THERAPEUTICS INC.

Finance

Bedrijven in privébezit22

Health Technology

Health Technology

Health Technology

Miscellaneous

Health Technology

Health Technology

Health Technology

Commercial Services

Health Services

Commercial Services

Commercial Services

Finance

Phenomix Australia Pty Ltd.

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Sardona Therapeutics, Inc.

Commercial Services

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Julie Cherrington
Alle transcripties over 9000 bedrijven, de dag van publicatie!
Krijg nu toegang!
fermer